Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage

A private, for-profit company has recently opened a pair of plasma donation centres in Canada, at which donors can be compensated up to $50 for their plasma. This has sparked a nation-wide debate around the ethics of paying plasma donors. Our aim in this paper is to shift the terms of the current d...

Full description

Bibliographic Details
Main Authors: Vida Panitch, Lendell Chad Horne
Format: Article
Language:English
Published: Programmes de bioéthique, École de santé publique de l'Université de Montréal 2019-03-01
Series:Canadian Journal of Bioethics
Subjects:
Online Access:https://cjb-rcb.ca/index.php/cjb-rcb/article/view/100
id doaj-d86482bef1bc432c9d7e4e23d00b8ff6
record_format Article
spelling doaj-d86482bef1bc432c9d7e4e23d00b8ff62021-04-02T10:51:09ZengProgrammes de bioéthique, École de santé publique de l'Université de MontréalCanadian Journal of Bioethics2561-46652019-03-0122Paying for Plasma: Commodification, Exploitation, and Canada's Plasma ShortageVida Panitch0Lendell Chad Horne1Department of Philosophy, Carleton University, Ottawa, CanadaDepartment of Philosophy, Franklin & Marshall College, Lancaster, USA A private, for-profit company has recently opened a pair of plasma donation centres in Canada, at which donors can be compensated up to $50 for their plasma. This has sparked a nation-wide debate around the ethics of paying plasma donors. Our aim in this paper is to shift the terms of the current debate away from the question of whether plasma donors should be paid and toward the question of who should be paying them. We consider arguments against paying plasma donors grounded in concerns about exploitation, commodification, and the introduction of a profit motive. We find them all to be normatively inconclusive, but also overbroad in light of Canada’s persistent reliance on plasma from paid donors in the United States. While we believe that there are good reasons to oppose allowing a private company to profit from Canada’s blood supply, these concerns can be addressed if payment is dispensed instead by a public, not-for-profit agency. In short, we reject profiting from plasma while we endorse paying for plasma; we therefore conclude in favour of a new Canadian regime of public sector plasma collection and compensation. https://cjb-rcb.ca/index.php/cjb-rcb/article/view/100CommodificationExploitationPlasmaBlood DonationProfit
collection DOAJ
language English
format Article
sources DOAJ
author Vida Panitch
Lendell Chad Horne
spellingShingle Vida Panitch
Lendell Chad Horne
Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
Canadian Journal of Bioethics
Commodification
Exploitation
Plasma
Blood Donation
Profit
author_facet Vida Panitch
Lendell Chad Horne
author_sort Vida Panitch
title Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
title_short Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
title_full Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
title_fullStr Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
title_full_unstemmed Paying for Plasma: Commodification, Exploitation, and Canada's Plasma Shortage
title_sort paying for plasma: commodification, exploitation, and canada's plasma shortage
publisher Programmes de bioéthique, École de santé publique de l'Université de Montréal
series Canadian Journal of Bioethics
issn 2561-4665
publishDate 2019-03-01
description A private, for-profit company has recently opened a pair of plasma donation centres in Canada, at which donors can be compensated up to $50 for their plasma. This has sparked a nation-wide debate around the ethics of paying plasma donors. Our aim in this paper is to shift the terms of the current debate away from the question of whether plasma donors should be paid and toward the question of who should be paying them. We consider arguments against paying plasma donors grounded in concerns about exploitation, commodification, and the introduction of a profit motive. We find them all to be normatively inconclusive, but also overbroad in light of Canada’s persistent reliance on plasma from paid donors in the United States. While we believe that there are good reasons to oppose allowing a private company to profit from Canada’s blood supply, these concerns can be addressed if payment is dispensed instead by a public, not-for-profit agency. In short, we reject profiting from plasma while we endorse paying for plasma; we therefore conclude in favour of a new Canadian regime of public sector plasma collection and compensation.
topic Commodification
Exploitation
Plasma
Blood Donation
Profit
url https://cjb-rcb.ca/index.php/cjb-rcb/article/view/100
work_keys_str_mv AT vidapanitch payingforplasmacommodificationexploitationandcanadasplasmashortage
AT lendellchadhorne payingforplasmacommodificationexploitationandcanadasplasmashortage
_version_ 1724166721182367744